The genetic risk for COVID-19 severity is associated with defective innate immune responses
Yunus Kuijpers, Xiaojing Chu, Martin Jaeger, Simone J.C.F.M. Moorlag, Valerie A. C. M. Koeken, Bowen Zhang, Aline de Nooijer, Inge Grondman, Manoj Kumar Gupta, Nico A. F. Janssen, Vera P. Mourits, L. Charlotte J. de Bree, Quirijn de Mast, Frank L. van de Veerdonk, Leo A. B. Joosten, , Cheng‐Jian Xu
This study explores the physiological significance of genetic variants associated with COVID-19 severity using clinical, immunological, and multi-omics data from large cohorts, identifying pathways for prevention and therapy.
Frontiers in Immunology · May 12, 2022Peer-reviewedGenetic & Genomic Medicine